Neutrophils assist the metastasis of circulating tumor cells in pancreatic ductal adenocarcinoma: A new hypothesis and a new predictor for distant metastasis.
During our research on circulating tumor cells (CTCs) derived from tumor-adjacent vessels in pancreatic ductal adenocarcinoma (PDAC), we found that CTCs are sometimes surrounded by white blood cells (WBCs) in blood. We hypothesize that such interaction between WBCs and CTCs in blood is a mechanism by which WBCs assist in the metastasis of CTCs. We present our laboratory finding, with our evaluation of the association between the neutrophil-to-lymphocyte ratio (NLR, the most investigated clinical parameter of WBCs) and distant metastasis after curative surgery in PDAC. The laboratory finding was presented through immunofluorescence. In the clinical segment, we performed a retrospective study on PDAC patients with distant metastasis after curative surgery who were referred to Peking University Third Hospital between 2005 and 2014. The data on the possible clinical factors were collected by a retrospective review of the patients' records. Immunofluorescence results showed that CTCs are surrounded by WBCs in tumor-adjacent vessels of PDAC patients. In the clinical segment, 112 (70%) of a total of 160 PDAC patients were found to have developed distant metastases after surgery; among the 112 patients, only 89 had entire data and were enrolled for further analysis (84.3% patients had liver metastasis). No significant association was found between the NLR and overall survival (hazard ratio [HR] = 1.027, 95% confidence interval [CI] 0.723-1.459, P = 0.88); however, a significant relationship between the NLR and distant metastasis after curative surgery was found on the univariate (HR = 1.641, 95% CI 1.058-2.545, P = 0.027) and multivariate analyses (HR = 2.15, 95% CI 1.279-3.615, P = 0.004). Neutrophils might assist in distant metastasis through interaction with CTCs in blood. Moreover, NLR is an effective predictor for distant metastasis after curative surgery for PDAC.
Department of General Surgery, Peking University Third Hospital, Beijing, China.
Lianyuan
L
Tao
Lingfu
L
Zhang
Ying
Y
Peng
Ming
M
Tao
Lei
L
Li
Dianrong
D
Xiu
Chunhui
C
Yuan
Zhaolai
Z
Ma
Bin
B
Jiang
D000230:Adenocarcinoma / Q000097:blood / Q000473:pathology / Q000556:secondary*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002450:Cell Communication; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000097:blood / Q000556:secondary; D018655:Lymphocyte Count; D008214:Lymphocytes / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009360:Neoplastic Cells, Circulating / Q000473:pathology*; D009504:Neutrophils / Q000502:physiology*; D010183:Pancreatic Ducts / Q000473:pathology; D010190:Pancreatic Neoplasms / Q000097:blood / Q000473:pathology*; D011237:Predictive Value of Tests; D016016:Proportional Hazards Models; D012189:Retrospective Studies; D055815:Young Adult
Mediators Inflamm. 2016;2016:6058147
26966341
Am J Physiol Cell Physiol. 2001 Apr;280(4):C814-22
11245598
Future Oncol. 2011 Jul;7(7):849-71
21732757
Cancer Res. 2010 Jul 15;70(14):6071-82
20610626
Anticancer Res. 2007 Jan-Feb;27(1A):17-22
17352210
Cancer Immunol Res. 2016 Feb;4(2):83-91
26839309
N Engl J Med. 2010 Apr 29;362(17):1605-17
20427809
Semin Immunol. 2016 Apr;28(2):197-204
26976824
J Thromb Haemost. 2013 Jun;11(6):1172-82
23581432
Med Oncol. 2012 Dec;29(5):3092-100
22476808
Cardiovasc Res. 1995 Nov;30(5):676-81
8595612
Tumour Biol. 2014 Mar;35(3):2473-80
24218336
J Neurooncol. 2012 Oct;110(1):27-36
22842979
Cell Mol Life Sci. 2007 Dec;64(24):3306-16
17994288
Theor Biol Med Model. 2014 Apr 12;11:17
24725600
EMBO Mol Med. 2014 Nov 14;7(1):1-11
25398926
Microcirculation. 2009 Jan;16(1):31-42
19037827
Drug Metab Dispos. 2011 Oct;39(10):1910-20
21768275
Tumori. 2013 Jul-Aug;99(4):516-22
24326841
Oncoimmunology. 2014 Jul 03;3(7):e950163
25610737
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1853-8
11172040
Eur J Cancer. 2005 May;41(7):1065-72
15862757
Nature. 2015 Dec 17;528(7582):413-7
26649828
J Biol Chem. 2011 Oct 7;286(40):34777-87
21840991
Cancer Res. 2003 May 1;63(9):2079-87
12727823
J Immunol. 2001 Oct 1;167(7):4017-25
11564821
Cell. 2014 Aug 28;158(5):1110-22
25171411
Clin Exp Metastasis. 2002;19(8):717-25
12553378
Tumour Biol. 2016 Apr;37(4):5397-404
26563367
J Invest Dermatol. 2010 Sep;130(9):2259-68
20505748
Cancer J. 2015 May-Jun;21(3):188-93
26049698
Gastroenterol Res Pract. 2016;2016:8962321
26941789
Br J Cancer. 2012 Sep 4;107(6):988-93
22878374
Ann Surg Oncol. 2010 Jun;17(6):1471-4
20180029
Ann Surg Oncol. 2015 Feb;22(2):670-6
25155401
Cancer Med. 2014 Apr;3(2):406-15
24519894
Oncol Lett. 2016 Feb;11(2):1294-1298
26893733
J Immunol. 1999 Nov 1;163(9):5029-38
10528208
Oncotarget. 2016 Apr 26;7(17):24677-87
27013581
Exp Cell Res. 2010 Jan 1;316(1):138-48
19747913
J Biol Chem. 2005 Nov 4;280(44):37021-32
16115878
Br J Cancer. 2012 May 22;106(11):1833-41
22617157